Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6523
pubmed:dateCreated
1986-5-22
pubmed:abstractText
Nephrotic syndrome in minimal change lipoid nephrosis and focal segmental glomerulosclerosis may be due to alteration of glomerular anionic sites by a lymphokine. Six adults with nephrotic syndrome who were resistant to treatment with corticosteroids and immunosuppressants were treated with cyclosporin A. In three patients with minimal change lipoid nephrosis who had been nephrotic for 3.5 to 23 years proteinuria resolved within 12 to 42 days. Subsequently, these patients became dependent on cyclosporin A. In three patients with focal segmental glomerulosclerosis who had been nephrotic for four to six years mean (SD) 24 hour urinary protein decreased from 14.7 (8.4) g to 3.6 (0.6) g within 20 to 25 days, serum albumin concentration rose, and oedema subsided. One patient died of myocardial infarction when still in partial remission after 11 weeks' treatment. Two patients remained proteinuric despite continuing treatment with cyclosporin A, but control of sodium balance was easy and serum albumin concentrations remained higher than without cyclosporin A. In all patients renal function improved during treatment. These preliminary results show that cyclosporin A may be effective in the treatment of patients with nephrotic syndrome that resists every other form of treatment and especially in the treatment of those with minimal change lipoid nephrosis. The results are in keeping with a T lymphocyte mediated mechanism of minimal change lipoid nephrosis and focal segmental glomerulosclerosis, but they also suggest that minimal change lipoid nephrosis and focal segmental glomerulosclerosis are separate entities.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-1079322, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-1174637, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-2859508, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-2862418, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-314370, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-322900, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-3982574, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-4114718, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-4140273, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6383672, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6392692, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6406074, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6456149, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6459374, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6601737, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6611510, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6753596, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-6848563, http://linkedlifedata.com/resource/pubmed/commentcorrection/3082443-699400
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0267-0623
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
292
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
789-92
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.
pubmed:publicationType
Journal Article, Case Reports